SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies | RMD Open

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Archive

For authors

About

Podcasts
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Connective tissue diseases

Original research

SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies

Online download statistics by month:

Online download statistics by month: February 2022 to March 2024

	Abstract	Full	Pdf
Feb 2022	396	397	106
Mar 2022	218	213	79
Apr 2022	110	102	49
May 2022	148	146	59
Jun 2022	87	90	38
Jul 2022	123	120	41
Aug 2022	113	113	56
Sep 2022	103	106	44
Oct 2022	205	207	70
Nov 2022	219	216	37
Dec 2022	68	69	30
Jan 2023	92	92	28
Feb 2023	92	85	32
Mar 2023	74	68	27
Apr 2023	44	43	15
May 2023	92	88	25
Jun 2023	46	52	31
Jul 2023	70	67	33
Aug 2023	66	64	18
Sep 2023	83	82	25
Oct 2023	66	66	25
Nov 2023	76	70	22
Dec 2023	66	63	37
Jan 2024	78	76	24
Feb 2024	54	53	37
Mar 2024	77	76	37
Total	2866	2824	1025